Cover Image
市場調查報告書

美國的分子診斷市場:檢查數量預測及企業

United States (USA) - Molecular Diagnostics Market, Test Volume Forecast & Companies

出版商 Renub Research 商品編碼 300967
出版日期 內容資訊 英文 128 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的分子診斷市場:檢查數量預測及企業 United States (USA) - Molecular Diagnostics Market, Test Volume Forecast & Companies
出版日期: 2014年05月05日 內容資訊: 英文 128 Pages
簡介

分子診斷是急速進化的領域,新的技術和應用領域不斷追加。分子診斷從目前以症狀和代理標記的使用為基礎的病情診斷,換成基因和蛋白質體學分析的診斷,是有潛力的領域。美國的分子診斷市場至2018年將擴大到目前的二倍以上。

本報告提供美國的分子診斷市場相關調查、市場概要和數量、各方面應用的預測、各企業趨勢、市場課題等彙整資料,為您概述為以下內容。

第1章 摘要整理

第2章 美國的分子診斷市場:檢查數量與預測

  • 市場及預測
  • 檢查數量及預測

第3章 美國的分子診斷市場及數量市場佔有率

第4章 美國的分子診斷市場及預測:各方面應用

  • 癌症檢驗
    • 乳癌
    • 大腸癌
    • 前列腺癌
    • 其他
  • 傳染病檢查
    • 病毒檢驗
    • 人類乳突病毒(HPV)檢驗
    • HAI檢驗
    • 重症加護檢驗
  • 遺傳基因檢驗市場
  • 血液篩檢市場
  • 食品病原菌檢驗市場
  • 組織型決策(HLA)檢驗市場

第5章 美國的分子診斷檢查數量:各方面應用

  • 癌症檢驗
  • 傳染病檢查
  • 遺傳基因檢驗市場

第6章 美國的分子診斷市場:各企業

  • Roche
  • Abbott Laboratories
  • Myriad Genetics
  • Biomerieux
  • Qiagen
  • Hologic Inc.
  • Becton Dickinson
  • Siemens
  • Cepheid

第7章 促進要素

第8章 課題

圖表

目錄

Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being added continuously. Molecular diagnostics is the promising area which can transform disease diagnosis, as diagnosis based on symptoms and use of surrogate markers is replaced by genomic and proteomic analysis. This fundamental shift offers the promise for early disease detection, potentially before symptoms have even occurred.

United States molecular diagnostic market for 2018 is anticipated to more than double from its current value in 2013. In United States molecular diagnostic market, infectious disease controls the highest market share in 2013.

But in terms of test volume food pathogen testing takes the lead pushing infectious disease at number two position.

Molecular oncology tests have emerged as a significant rapidly growing market segment. In the current medical diagnostics market, molecular diagnostics for cancer testing offers one of the brightest areas for growth and innovation. United States constitutes the largest regional market for blood screening and blood products. Molecular diagnostics is also starting to emerge as an important tool for HLA Testing, Food Pathogen Detection Testing and other disease areas.

In companies market share Hologic Inc., Myriad Genetics and Becton Dickinson together these 3 companies control more than 50% market share for 2013. However Becton Dickinson is expected to lose its market share gradually and Roche is expected to take its place by 2018.

United States Molecular Diagnostics Market & Test Volume - Application Segment Analysis (2010 - 2018)

  • 1. Oncology Testing
    • a) Breast Cancer
    • b) Colorectal Cancer
    • c) Prostate Cancer
    • d) Others
  • 2. Infectious Diseases
    • a) Virology Testing
    • b) HPV Testing
    • c) HAI Testing
    • d) Critical Care Testing
  • 3. Genetic Testing
  • 4. Blood Screening
  • 5. Food Pathogen Testing
  • 6. Tissue Typing (HLA Testing)

United States Molecular Diagnostics - Company Wise Sales Analysis (2010 - 2018)

  • 1. Roche
  • 2. Abbott
  • 3. Myriad Genetics
  • 4. BioMerieux
  • 5. Qiagen
  • 6. Hologic Inc.
  • 7. Becton Dickinson
  • 8. Siemens
  • 9. Cepheid
  • 10. Others

Renub Research study titled "United States (USA)-Molecular Diagnostics Market, Test Volume Forecast & Companies " provides a comprehensive assessment of the fast-evolving, high-growth Global Molecular Diagnostics Market. This 128 page report with 87 Figures studies the United States Molecular Diagnostics from 4 view points: 1) Market and Forecast 2) Application Wise Market & Forecast 3) Application Wise Test Volume & Forecast 4) Company Wise Molecular Diagnostics Sales & Forecast

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.

Table of Contents

1. Executive Summary

2. United States Molecular Diagnostics Market, Test Volume & Forecast (2010 - 2018)

  • 2.1 United States Molecular Diagnostics Market & Forecast
  • 2.2 United States Molecular Diagnostics Test Volume & Forecast

3. United States Molecular Diagnostics Market & Volume Share (2010 - 2018)

  • 3.1 United States Molecular Diagnostics Market Share & Forecast - Application Wise
  • 3.2 United States Molecular Diagnostics Market Share & Forecast - Company Wise
  • 3.3 United States Molecular Diagnostics Test Volume Share & Forecast - Application Wise

4. United States Molecular Diagnostics Market & Forecast - Application Wise

  • 4.1 Oncology Testing Market (2004 - 2018)
    • 4.1.1 Breast Cancer Testing Market (2004 - 2018)
    • 4.1.2 Colorectal Cancer Testing Market (2004 - 2018)
    • 4.1.3 Prostate Cancer Testing Market (2004 - 2018)
    • 4.1.4 Other Cancer Testing Market (2004 - 2018)
  • 4.2 Infectious Disease Testing Market (2010 - 2018)
    • 4.2.1 Virology Testing Market (2007 - 2018)
    • 4.2.2 HPV Testing Market (2004 - 2018)
    • 4.2.3 HAI Testing Market (2010 - 2018)
    • 4.2.4 Critical Care Testing Market (2010 - 2018)
  • 4.3 Genetic Testing Market (2010 - 2018)
  • 4.4 Blood Screening Market (2006 - 2018)
  • 4.5 Food Pathogen Testing Market (2010 - 2018)
  • 4.6 Tissue Typing (HLA) Testing Market (2008 - 2018)

5. United States Molecular Diagnostics Test Volume - Application Wise

  • 5.1 Oncology Test Volume (2004 - 2018)
    • 5.1.1 Breast Cancer Test Volume (2004 - 2018)
    • 5.1.2 Colorectal Cancer Test Volume (2004 - 2018)
    • 5.1.3 Prostate Cancer Test Volume (2004 - 2018)
    • 5.1.4 Other Cancer Test Volume (2004 - 2018)
  • 5.2 Infectious Disease Test Volume (2010 - 2018)
    • 5.2.1 Virology Test Volume (2007 - 2018)
    • 5.2.2 HPV Test Volume (2004 - 2018)
    • 5.2.3 HAI Test Volume (2010 - 2018)
    • 5.2.4 Critical Care Test Volume (2010 - 2018)
  • 5.3 Genetic Testing Test Volume & Forecast (2010 - 2018)
    • 5.4 Blood Screening Test Volume & Forecast (2006 - 2018)
    • 5.5 Food Pathogen Test Volume & Forecast (2010 - 2018)
    • 5.6 HLA Test Volume & Forecast (2008 - 2018)

6. United States Molecular Diagnostics Market - Company Wise

  • 6.1 Roche - United States Molecular Diagnostic Sales and Forecast
  • 6.2 Abbott Laboratories - United States Molecular Diagnostic Sales and Forecast
  • 6.3 Myriad Genetics - United States Molecular Diagnostic Sales and Forecast
  • 6.4 Biomerieux - United States Molecular Diagnostic Sales and Forecast
  • 6.5 Qiagen - United States Molecular Diagnostic Sales and Forecast
  • 6.6 Hologic Inc. (Acquired Gen-Probe) - United States Molecular Diagnostic Sales and Forecast
  • 6.7 Becton Dickinson - United States Molecular Diagnostic Sales and Forecast
  • 6.8 Siemens - United States Molecular Diagnostic Sales and Forecast
  • 6.9 Cepheid - United States Molecular Diagnostic Sales and Forecast
  • 6.10 Others - United States Molecular Diagnostic Sales and Forecast

7. United States Molecular Diagnostics Market - Driving Factors

  • 7.1 Point A
  • 7.2 Point B
  • 7.3 Point C

8. United States Molecular Diagnostics Market - Challenges

  • 8.1 Point A
  • 8.2 Point B
  • 8.3 Point C

List of Figures:

  • Figure 2-1: United States - Molecular Diagnostics Market (Million US$), 2010 - 2013
  • Figure 2-2: United States - Forecast for Molecular Diagnostics Market (Million US$), 2014 - 2018
  • Figure 2-3: United States - Molecular Diagnostics Test Volume (Million), 2010 - 2013
  • Figure 2-4: United States - Forecast for Molecular Diagnostics Test Volume (Million), 2014 - 2018
  • Figure 3-1: United States - Molecular Diagnostics Applications Market Share (Percent), 2010 - 2013
  • Figure 3-2: United States - Forecast for Molecular Diagnostics Applications Market Share (Percent), 2014 - 2018
  • Figure 3-3: United States - Company Wise Molecular Diagnostics Market Share (Percent), 2010 - 2013
  • Figure 3-4: United States - Forecast for Company Wise Molecular Diagnostics Market Share (Percent), 2014 - 2018
  • Figure 3-5: United States - Molecular Diagnostics Applications Test Volume Share (Percent), 2010 - 2013
  • Figure 3-6: United States - Forecast for Molecular Diagnostics Applications Test Volume Share (Percent), 2014 - 2018
  • Figure 4-1: United States - Molecular Diagnostic Oncology Testing Market (Million US$), 2004 - 2013
  • Figure 4-2: United States - Forecast for Molecular Diagnostic Oncology Testing Market (Million US$), 2014 - 2018
  • Figure 4-3: United States - Molecular Diagnostic Breast Cancer Testing Market (Million US$), 2004 - 2013
  • Figure 4-4: United States - Forecast for Molecular Diagnostic Breast Cancer Testing Market (Million US$), 2014 - 2018
  • Figure 4-5: United States - Molecular Diagnostic Colorectal Cancer Testing Market (Million US$), 2004 - 2013
  • Figure 4-6: United States - Forecast for Molecular Diagnostic Colorectal Cancer Testing Market (Million US$), 2014 - 2018
  • Figure 4-7: United States - Molecular Diagnostic Prostate Cancer Testing Market (Million US$), 2004 - 2013
  • Figure 4-8: United States - Forecast for Molecular Diagnostic Prostate Cancer Testing Market (Million US$), 2014 - 2018
  • Figure 4-9: United States - Other Molecular Diagnostic Cancer Testing Market (Million US$), 2004 - 2013
  • Figure 4-10: United States - Forecast for Other Molecular Diagnostic Cancer Testing Market (Million US$), 2014 - 2018
  • Figure 4-11: United States - Infectious Disease Testing Market (Million US$), 2010 - 2013
  • Figure 4-12: United States - Forecast for Infectious Disease Testing Market (Million US$), 2014 - 2018
  • Figure 4-13: United States - Virology Testing Market (Million US$), 2007 - 2018
  • Figure 4-14: United States - Forecast for Virology Testing Market (Million US$), 2014 - 2018
  • Figure 4-15: United States - HPV Testing Market (Million US$), 2004 - 2013
  • Figure 4-16: United States - Forecast for HPV Testing Market (Million US$), 2014 - 2018
  • Figure 4-17: United States - HAI Testing Market (Million US$), 2010 - 2013
  • Figure 4-18: United States - Forecast for HAI Testing Market (Million US$), 2014 - 2018
  • Figure 4-19: United States - Critical Care Testing Market (Million US$), 2010 - 2013
  • Figure 4-20: United States - Forecast for Critical Care Testing Market (Million US$), 2014 - 2018
  • Figure 4-21: United States - Genetic Testing Market (Million US$), 2010 - 2013
  • Figure 4-22: United States - Forecast for Genetic Testing Market (Million US$), 2014 - 2018
  • Figure 4-23: United States - Blood Screening Market (Million US$), 2006 - 2013
  • Figure 4-24: United States - Forecast for Blood Screening Market (Million US$), 2014 - 2018
  • Figure 4-25: United States - Food Pathogen Testing Market (Million US$), 2010 - 2013
  • Figure 4-26: United States - Forecast for Food Pathogen Testing Market (Million US$), 2014 - 2018
  • Figure 4-27: United States - HLA Testing Market (Million US$), 2008 - 2013
  • Figure 4-28: United States - Forecast for HLA Testing Market (Million US$), 2014 - 2018
  • Figure 5-1: United States - Oncology Test Volume (Million), 2004 - 2013
  • Figure 5-2: United States - Forecast for Oncology Test Volume (Million), 2014 - 2018
  • Figure 5-3: United States - Breast Cancer Test Volume (Million), 2004 - 2013
  • Figure 5-4: United States - Forecast for Breast Cancer Test Volume (Million), 2014 - 2018
  • Figure 5-5: United States - Colorectal Cancer Test Volume (Million), 2004 - 2013
  • Figure 5-6: United States - Forecast for Colorectal Cancer Test Volume (Million), 2014 - 2018
  • Figure 5-7: United States - Prostate Cancer Test Volume (Million), 2004 - 2013
  • Figure 5-8: United States - Forecast for Prostate Cancer Test Volume (Million), 2014 - 2018
  • Figure 5-9: United States - Other Cancer Test Volume (Million), 2004 - 2013
  • Figure 5-10: United States - Forecast for Other Cancer Test Volume (Million), 2014 - 2018
  • Figure 5-11: United States - Infectious Disease Test Volume (Million), 2010 - 2013
  • Figure 5-12: United States - Forecast for Infectious Disease Test Volume (Million), 2014 - 2018
  • Figure 5-13: United States - Virology Test Volume (Million), 2007 - 2018
  • Figure 5-14: United States - Forecast for Virology Test Volume (Million), 2014 - 2018
  • Figure 5-15: United States - HPV Test Volume (Million), 2004 - 2013
  • Figure 5-16: United States - Forecast for HPV Test Volume (Million), 2014 - 2018
  • Figure 5-17: United States - HAI Test Volume (Million), 2010 - 2013
  • Figure 5-18: United States - Forecast for HAI Test Volume (Million), 2014 - 2018
  • Figure 5-19: United States - Critical Care Test Volume (Million), 2010 - 2013
  • Figure 5-20: United States - Forecast for Critical Care Test Volume (Million), 2014 - 2018
  • Figure 5-21: United States - Genetic Testing Test Volume (Million), 2010 - 2013
  • Figure 5-22: United States - Forecast for Genetic Testing Test Volume (Million), 2014 - 2018
  • Figure 5-23: United States - Blood Screening Test Volume (Million), 2006 - 2013
  • Figure 5-24: United States - Forecast for Blood Screening Test Volume (Million), 2014 - 2018
  • Figure 5-25: United States - Food Pathogen Test Volume (Million), 2010 - 2013
  • Figure 5-26: United States - Forecast for Food Pathogen Test Volume (Million), 2014 - 2018
  • Figure 5-27: United States - HLA Test Volume (Million), 2008 - 2013
  • Figure 5-28: United States - Forecast for HLA Test Volume (Million), 2014 - 2018
  • Figure 6-1: Roche - United States Molecular Diagnostic Sales (Million US$), 2008 - 2013
  • Figure 6-2: Roche - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
  • Figure 6-3: Abbott Laboratories - United States Molecular Diagnostic Sales (Million US$), 2010 - 2013
  • Figure 6-4: Abbott Laboratories - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
  • Figure 6-5: Myriad Genetics - United States Molecular Diagnostic Sales (Million US$), 2007 - 2013
  • Figure 6-6: Myriad Genetics - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
  • Figure 6-7: Biomerieux - United States Molecular Diagnostic Sales (Million US$), 2010 - 2013
  • Figure 6-8: Biomerieux - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
  • Figure 6-9: Qiagen - United States Molecular Diagnostic Sales (Million US$), 2010 - 2013
  • Figure 6-10: Qiagen - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
  • Figure 6-11: Hologic-Gen-Probe - United States Molecular Diagnostic Sales (Million US$), 2010 - 2013
  • Figure 6-12: Hologic-Gen-Probe - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
  • Figure 6-13: Becton Dickinson - United States Molecular Diagnostic Sales (Million US$), 2010 - 2013
  • Figure 6-14: Becton Dickinson - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
  • Figure 6-15: Siemens - United States Molecular Diagnostic Sales (Million US$), 2008 - 2013
  • Figure 6-16: Siemens - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
  • Figure 6-17: Cepheid - United States Molecular Diagnostic Sales (Million US$), 2010 - 2013
  • Figure 6-18: Cepheid - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
  • Figure 6-19: Others - United States Molecular Diagnostic Sales (Million US$), 2010 - 2013
  • Figure 6-20: Others - Forecast for United States Molecular Diagnostic Sales (Million US$), 2014 - 2018
  • Figure 7-1: United States - Investment in the Human Genome Project (Billion US$), 2003, 2012
Back to Top